Jump to content

Jessica Borger: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m Duplicate word removed
removing uncategorisez issue
Line 40: Line 40:
{{Authority control|ORCID=0000-0003-0704-1254}}
{{Authority control|ORCID=0000-0003-0704-1254}}


[[Category: living people]]
{{uncategorized|date=August 2020}}

Revision as of 12:53, 18 August 2020

Jessica Geraldine Borger
NationalityAustralian
Alma materUniversity of South Australia, University of Edinburgh, University College London

Jessica Geraldine Borger is an Australian T Cell immunologist, Lecturer and Graduate Course Coordinator at the Central Clinical School, Monash University[1]. Her research has added to the understanding of the molecular mechanisms of T cell function[2]. Additionally, Borger is a Guest Associate Editor for Frontiers in Immunology[3], News and Commentary Editor for Immunology & Cell Biology[4] and a reviewer for several academic journals[1]. Jessica also advocates for gender equality in Science, Technology, Engineering and Mathematics (STEM) in her position a member of the Gender Equity, Diversity[disambiguation needed] and Inclusion committee of the Central Clinical School at Monash University.

Education

Borger started her studying towards her undergraduate degree when she was 21 years old[5]. She received a Bachelor's Degree in Medical and Pharmaceutical Biotechnology from the University of South Australia[1]. Eight years after completing her Bachelor's degree, Jessica moved to the UK to begin her PhD at University College London after being awarded a highly competitive Medical Research Council[disambiguation needed] PhD scholarship by the National Institute of Medical Research[1][5]. During her PhD, she began researching T Cell function with Rose Zamoyska, specifically investigating the role of Caveolin-1 in T cell cholesterol homeostasis, integrin signaling and exosome complex biogenesis[1].

Career

Research

Between completing her Bachelor's degree and starting her PhD, Borger worked as a Molecular Biologist for GRMicro (2002 - 2003), and for Borger worked for Arrow Therapeutics as a Drug Discovery Scientist (2003 - 2006)[6].

In 2016, Borger took a position in the Central Clinical School at Monash University as a Senior Postdoctoral Researcher. In this position, Jessica has been researching gamma delta T cell development, activation and function as potential targets of therapeutic intervention of lung disorders[1][3]. Additionally, Jessica was awarded a CASS Foundation Medicine/Science grant to research the design of novel CAR-T therapy approaches in the lung using novel intracellular checkpoint blockade targets[1][7]. In 2017, she was awarded the Best Postdoctoral Speaker Award and the Best Presentation Price by the Immunology Alfred Hospital[8][9].

In 2019, Borger became Lecturer and Course-Coordinator of Graduate Studies at Monash University. In this role, she created a Master's course in Translational Research[1]. In the same year, Borger was the first recipient of the Margaret Baird Women in Immunology Award by the Australian and New Zealand Society for Immunology[10][11].

Science Communication and Gender Equality Advocacy

Borger is an advocate for gender equality in STEM and science communicator. She has written articles for Women's Agenda[12], The Conversation[6], Women in STEMM Australia[13] and EconoTimes[14].

In 2018, Borger sat on the committee Gender, Equity, Diversity and Inclusion (GEDI) at Central Clinical School at Monash University[15][1]. This committee conducted a survey to investigate problems and concerns with GEDI issues in the school[16]. In the same year, Jessica Borger was awarded the Veski Inspiring women STEM sidebyside scholarship[17][1][3].

Borger also sits on the organising committee for the Lorne Infection and Immunity Conference 2021[16][1].

Publications

Borger's published works include:

References

  1. ^ a b c d e f g h i j k "Jessica Borger". Monash University. Retrieved 2020-08-16.
  2. ^ "Jessica Borger". STEM Women. Retrieved 2020-08-16.
  3. ^ a b c "Loop | Jessica Borger". loop.frontiersin.org. Retrieved 2020-08-16.
  4. ^ "Immunology & Cell Biology". Wiley Online Library. Retrieved 2020-08-16.
  5. ^ a b Watton, Isla (2019-05-29). "You are a unique product of your own passions, drive and opportunities: Meet Jessica Borger". SoapboxScience. Retrieved 2020-08-17.
  6. ^ a b "Jessica Borger". The Conversation. Retrieved 2020-08-17.
  7. ^ "Jessica Borger". Monash Lens. Retrieved 2020-08-17.
  8. ^ "Best Postdoctoral Speaker Award". Monash University. Retrieved 2020-08-17.
  9. ^ "Best Presentation Prize". Monash University. Retrieved 2020-08-17.
  10. ^ "Margaret Baird Women in Immunology Lectureship". Monash University. Retrieved 2020-08-16.
  11. ^ Media, Gloss Creative. "ASI 2019 – Awards and Special Honours". www.immunology.org.au. Retrieved 2020-08-16.
  12. ^ "Dr Jessica Borger, Author at Women's Agenda". Women's Agenda. Retrieved 2020-08-17.
  13. ^ Australia, Women in STEMM (2018-12-05). "Once you've left can you really break back in?". Women in STEMM Australia. Retrieved 2020-08-17.
  14. ^ "Breaking News, Business, Financial and Economic News, World News from EconoTimes". EconoTimes. 2018-07-14. Retrieved 2020-08-17.
  15. ^ "Central Clinical School News Blog: Eye on GEDI: Gender, Equity, Diversity and Inclusion at CCS". Central Clinical School News Blog. 2018-07-27. Retrieved 2020-08-17.
  16. ^ a b "Conference Committee". Lorne Infection & Immunity 2021. Retrieved 2020-08-17.
  17. ^ "2018 Leading the Way Participants | veski". www.veski.org.au. Retrieved 2020-08-17.
  18. ^ Borger, Jessica G.; Lau, Maverick; Hibbs, Margaret L. (2019). "The Influence of Innate Lymphoid Cells and Unconventional T Cells in Chronic Inflammatory Lung Disease". Frontiers in Immunology. 10. doi:10.3389/fimmu.2019.01597. ISSN 1664-3224.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  19. ^ Libri, Valentina; Helwak, Aleksandra; Miesen, Pascal; Santhakumar, Diwakar; Borger, Jessica G.; Kudla, Grzegorz; Grey, Finn; Tollervey, David; Buck, Amy H. (2012-01-03). "Murine cytomegalovirus encodes a miR-27 inhibitor disguised as a target". Proceedings of the National Academy of Sciences. 109 (1): 279–284. doi:10.1073/pnas.1114204109. ISSN 0027-8424. PMC 3252920. PMID 22184245.
  20. ^ Borger, Jessica G.; Cardenas-Maestre, Juan Manuel; Zamoyska, Rose; Sanchez-Martin, Rosario M. (2011-10-19). "Novel Strategy for Microsphere-Mediated DNA Transfection". Bioconjugate Chemistry. 22 (10): 1904–1908. doi:10.1021/bc200289n. ISSN 1043-1802.